InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.60
(
0.11%
)
US TECH 100
19,485.20
(
0.27%
)
Dow Jones
42,122.99
(
0.50%
)
Brent Oil
70.88
(
-3.16%
)
Bitcoin
65,380.89
(
3.56%
)
Post# of 964
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

midastouch017

Send PM Follow Ignore
Followers 144
Posts 27709
Boards Moderated 3
Alias Born 02/07/2004

midastouch017

Re: midastouch017 post# 386

Thursday, 06/02/2022 8:49:56 AM

Thursday, June 02, 2022 8:49:56 AM

Post# of 964
Omidubicel, if approved, has the potential to improve outcomes for patients based on transplanter feedback and to potentially increase access for patients to get to transplant. Omidubicel, if approved, has the potential to treat approximately 2,000 – 2,500 patients each year in the U.S.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up